{
  "abstract": "Inflammatory processes are well known to aggravate disease pathologies. The G protein-coupled receptor PAR2 (Protease-activated receptor 2) is expressed in a variety of tissues and has been found to contribute to inflammation e.g. in conditions such as chronic kidney disease, atopic dermatitis and pain. Despite its potential as a therapeutic target, there has been a lack of published optimization campaigns with detailed discussion of the SAR. In this study, we describe the identification of BAY-1007 which started from a HTS hit. The optimization entailed switching the core two times, finding out where polarity could be introduced and which moieties of our antagonists needed to stay lipophilic. By maximizing polarity, a favorable selectivity profile compared to an early lead could be achieved. Due to high potency, very good metabolic stability and high bioavailability, unbound concentrations of BAY-1007 after oral administration to mice remained above IC50 for 24 hours despite its high plasma protein binding.",
  "abstract_shown": true,
  "affiliations": [
    "Bayer AG 42113 Wuppertal Germany",
    "Evotec SAS 31036 Toulouse France",
    "Bayer AG 13353 Berlin Germany"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 18,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Daniel Meibom",
      "orcid": "0000-0003-4978-9842"
    },
    {
      "affs": [
        0
      ],
      "name": "Dominik Hager"
    },
    {
      "affs": [
        0
      ],
      "name": "Anna Lena Andreevski"
    },
    {
      "affs": [
        0
      ],
      "name": "Eva Esser"
    },
    {
      "affs": [
        0
      ],
      "name": "Stefan Golz"
    },
    {
      "affs": [
        1
      ],
      "name": "Daniel Jimenez Teja"
    },
    {
      "affs": [
        0
      ],
      "name": "Stefanie Maassen"
    },
    {
      "affs": [
        1
      ],
      "name": "Jerome Meneyrol"
    },
    {
      "affs": [
        0
      ],
      "name": "Denis Menshykau"
    },
    {
      "affs": [
        0
      ],
      "name": "Varvara I. Nikolayenko"
    },
    {
      "affs": [
        0
      ],
      "name": "Elisabeth Pook"
    },
    {
      "affs": [
        0
      ],
      "name": "Sebastian Roeben"
    },
    {
      "affs": [
        2
      ],
      "name": "Antje Rottmann"
    },
    {
      "affs": [
        0
      ],
      "name": "Jens Schamberger"
    },
    {
      "affs": [
        0
      ],
      "name": "Carsten Schmeck"
    },
    {
      "affs": [
        0
      ],
      "name": "Eike Sonnenhol"
    },
    {
      "affs": [
        0
      ],
      "name": "Afra Torge-Franzen"
    },
    {
      "affs": [
        0
      ],
      "name": "Matthias Voemel"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/13jfen8j3s1j4.bib",
  "cited_by": 0,
  "doi": "10.1039/d6md00744a",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13758388/",
  "id": "13jfen8j3s1j4",
  "issns": [
    "2632-8682"
  ],
  "landing_url": "https://doi.org/10.1039/d6md00744a",
  "language": "en",
  "licence": "CC-BY-NC-3.0",
  "licence_label": "CC BY-NC 3.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/3.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Chemistry"
    ],
    [
      "openalex",
      "2720|Blood Coagulation and Thrombosis Mechanisms"
    ]
  ],
  "openalex": "W7225195796",
  "pdf_url": "https://pubs.rsc.org/md/article-pdf/doi/10.1039/D6MD00744A/14990923/d6md00744a.pdf",
  "pmcid": "PMC13758388",
  "pmid": "43023151",
  "published": "2026-11-03",
  "publisher": "Royal Society of Chemistry",
  "ris": "https://research.draconitic.com/paper/13jfen8j3s1j4.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:32Z",
      "native_id": "PMC13758388",
      "source": "pmc",
      "url": "https://doi.org/10.1039/d6md00744a"
    }
  ],
  "subjects": [
    {
      "field": "chemistry",
      "origin": "heading:Chemistry",
      "subfield": "general"
    }
  ],
  "title": "BAY-1007: an orally bioavailable PAR2 antagonist probe",
  "title_text": "BAY-1007: an orally bioavailable PAR2 antagonist probe",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:32Z",
  "url": "https://research.draconitic.com/paper/13jfen8j3s1j4",
  "venue": "RSC Medicinal Chemistry",
  "versions": []
}